BiTEing the Tumor
Author:
Affiliation:
1. Division of Hematology, Mayo Clinic, Rochester, MN
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.00223
Reference10 articles.
1. Immune Therapies in Multiple Myeloma
2. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
3. SOHO State of the Art Updates and Next Questions: T-Cell–Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor–Modified T Cells and Bispecific T-Cell–Engaging Agents
4. Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
5. T Cell–Activating Bispecific Antibodies in Cancer Therapy
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy;Blood Advances;2023-08-10
2. On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future;Expert Opinion on Pharmacotherapy;2022-08-10
3. Targeting the Microenvironment for Treating Multiple Myeloma;International Journal of Molecular Sciences;2022-07-10
4. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management;American Journal of Hematology;2022-05-23
5. The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond;Cancers;2021-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3